Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
Thierry Facon, Gordon Cook, Saad Z. Usmani et al. · Leukemia · 2022 · Randomised trial
Full textCC BY
Hematology
Filters3 filters applied
Year
Readable here
Study type
3 papersQuestions on this topic
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes
U Platzbecker, A Symeonidis, E N Oliva et al. · Leukemia · 2017 · Randomised trial
Full textCC BY
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy
J A Glaspy, J S Jadeja, G Justice et al. · British Journal of Cancer · 2002 · Randomised trial
Full textCC BY